Delivery Order SPE2DB20D3103-SPE2DB25FQ1U4
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of OPZELURA 1.5% Cream in 60-gram quantities, valued at $4,813.05. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The order is scheduled for ultimate completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,650.79 on September 15, 2025, for OPZELURA 1.5% Cream in 60-gram quantities, with final delivery scheduled by September 16, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,673.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities on July 21, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation and represents a competitively awarded contract. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for OPZELURA 1.5% Cream (60GM), a topical pharmaceutical product. This firm fixed price delivery order, valued at $6,096.29, is scheduled for completion by July 24, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award utilized competitive procedures with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in a 60-gram unit on September 4, 2025, with a ceiling value of $2,171.95. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of September 5, 2025. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of OPZELURA 1.5% Cream in 60-gram units with a ceiling value of $33.5K. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside, competitively awarded contract. The award was issued on September 27, 2025, with performance of work...
- The Defense Logistics Agency awarded a delivery order valued at $3,760.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,258.72 for OPZELURA 1.5% Cream 60GM on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single pharmaceutical product delivery under the company's larger contracting...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This contract, valued at $23,775.26, represents a firm fixed price delivery order with a completion date of June 2, 2025. The award was competitively procured without set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical procurement standards through open competition. The...
- The Defense Logistics Agency awarded a Delivery Order (4568090195) to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,480.01 under firm fixed pricing terms, with performance to be completed by May 1, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1U4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of OPZELURA 1.5% Cream in 60-gram quantities, with a ceiling value of $20,404.44. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen demonstrates significant capability in fulfilling Defense Department medical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and specialized medical commodities supporting the Defense Health Agency and broader military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 9/5/25 |